159 related articles for article (PubMed ID: 18418052)
1. The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor.
Böhlig L; Metzger R; Rother K; Till H; Engeland K
Cell Cycle; 2008 May; 7(9):1254-61. PubMed ID: 18418052
[TBL] [Abstract][Full Text] [Related]
2. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type.
Benini S; Perbal B; Zambelli D; Colombo MP; Manara MC; Serra M; Parenza M; Martinez V; Picci P; Scotlandi K
Oncogene; 2005 Jun; 24(27):4349-61. PubMed ID: 15824736
[TBL] [Abstract][Full Text] [Related]
3. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
Lin CG; Chen CC; Leu SJ; Grzeszkiewicz TM; Lau LF
J Biol Chem; 2005 Mar; 280(9):8229-37. PubMed ID: 15611078
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of CCN3 expression as a potential mechanism for melanoma progression.
Fukunaga-Kalabis M; Martinez G; Telson SM; Liu ZJ; Balint K; Juhasz I; Elder DE; Perbal B; Herlyn M
Oncogene; 2008 Apr; 27(18):2552-60. PubMed ID: 17968313
[TBL] [Abstract][Full Text] [Related]
5. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.
Fukunaga-Kalabis M; Martinez G; Liu ZJ; Kalabis J; Mrass P; Weninger W; Firth SM; Planque N; Perbal B; Herlyn M
J Cell Biol; 2006 Nov; 175(4):563-9. PubMed ID: 17101694
[TBL] [Abstract][Full Text] [Related]
6. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
Vallacchi V; Daniotti M; Ratti F; Di Stasi D; Deho P; De Filippo A; Tragni G; Balsari A; Carbone A; Rivoltini L; Parmiani G; Lazar N; Perbal B; Rodolfo M
Cancer Res; 2008 Feb; 68(3):715-23. PubMed ID: 18245471
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.
Bleau AM; Planque N; Lazar N; Zambelli D; Ori A; Quan T; Fisher G; Scotlandi K; Perbal B
J Cell Biochem; 2007 Aug; 101(6):1475-91. PubMed ID: 17340618
[TBL] [Abstract][Full Text] [Related]
8. Nephroblastoma overexpressed/cysteine-rich protein 61/connective tissue growth factor/nephroblastoma overexpressed gene-3 (NOV/CCN3), a selective adrenocortical cell proapoptotic factor, is down-regulated in childhood adrenocortical tumors.
Doghman M; Arhatte M; Thibout H; Rodrigues G; De Moura J; Grosso S; West AN; Laurent M; Mas JC; Bongain A; Zambetti GP; Figueiredo BC; Auberger P; Martinerie C; Lalli E
J Clin Endocrinol Metab; 2007 Aug; 92(8):3253-60. PubMed ID: 17566092
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
[TBL] [Abstract][Full Text] [Related]
10. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
[TBL] [Abstract][Full Text] [Related]
11. CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation.
van Roeyen CR; Eitner F; Scholl T; Boor P; Kunter U; Planque N; Gröne HJ; Bleau AM; Perbal B; Ostendorf T; Floege J
Kidney Int; 2008 Jan; 73(1):86-94. PubMed ID: 17914348
[TBL] [Abstract][Full Text] [Related]
12. Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins.
Planque N; Long Li C; Saule S; Bleau AM; Perbal B
J Cell Biochem; 2006 Sep; 99(1):105-16. PubMed ID: 16598765
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
[TBL] [Abstract][Full Text] [Related]
14. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.
Lin CG; Leu SJ; Chen N; Tebeau CM; Lin SX; Yeung CY; Lau LF
J Biol Chem; 2003 Jun; 278(26):24200-8. PubMed ID: 12695522
[TBL] [Abstract][Full Text] [Related]
15. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
Brigstock DR
Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
[TBL] [Abstract][Full Text] [Related]
16. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
17. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
18. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen.
Lafont J; Jacques C; Le Dreau G; Calhabeu F; Thibout H; Dubois C; Berenbaum F; Laurent M; Martinerie C
J Bone Miner Res; 2005 Dec; 20(12):2213-23. PubMed ID: 16294274
[TBL] [Abstract][Full Text] [Related]
19. The expression of ccn3(nov) gene in musculoskeletal tumors.
Manara MC; Perbal B; Benini S; Strammiello R; Cerisano V; Perdichizzi S; Serra M; Astolfi A; Bertoni F; Alami J; Yeger H; Picci P; Scotlandi K
Am J Pathol; 2002 Mar; 160(3):849-59. PubMed ID: 11891184
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
